Know Cancer

or
forgot password
  • cancer clinical trials in hershey, PA

  • Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    Childhood Lymphocyte Predominant Hodgkin Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage II Childhood Hodgkin Lymphoma
    Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer, Pain, Prostate Cancer
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Penn State Geisinger Cancer Center
    Hershey, Pennsylvania 17033
    Prostate Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Penn State Geisinger Cancer Center
    Hershey, Pennsylvania 17033
    Lung Cancer
    NCI HIGH PRIORITY CLINICAL TRIAL --- Prostatectomy Compared With Watchful Waiting in Treating Patients With Stage I or Stage II Prostate Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Prostate Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Head and Neck Cancer
    Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Infection, Multiple Myeloma and Plasma Cell Neoplasm
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Sarcoma
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Penn State Geisinger Cancer Center
    Hershey, Pennsylvania 17033
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Penn State Geisinger Cancer Center
    Hershey, Pennsylvania 17033
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Leukemia, Myelodysplastic Syndromes, Sarcoma
    Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
    Penn State Geisinger Cancer Center
    Hershey, Pennsylvania 17033
    Lung Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Bladder Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Sarcoma
    STI571 in Treating Patients With Recurrent Leukemia
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Prostate Cancer
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Brain and Central Nervous System Tumors
    Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Paclitaxel in Treating Patients With Ovarian Stromal Cancer
    Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Ovarian Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Brain and Central Nervous System Tumors
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Penn State Geisinger Cancer Center
    Hershey, Pennsylvania 17033
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lung Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Head and Neck Cancer
    Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Leukemia
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Prostate Cancer
    Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Leukemia
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Esophageal Cancer, Gastric Cancer
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer
    Anastrozole & ZD1839 Compared With Fulvestrant & ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer
    Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Endometrial Cancer
    Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Kidney Cancer
    Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
    Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Leukemia
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
    Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Childhood Langerhans Cell Histiocytosis, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Penn State Children's Hospital
    Hershey, Pennsylvania 17033-0850
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Kidney Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Colorectal Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Brain and Central Nervous System Tumors
    Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Neuroblastoma, Sarcoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Brain and Central Nervous System Tumors
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Colorectal Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Chronic Myeloproliferative Disorders
    Radiation Therapy in Treating Young Patients With Gliomas
    Penn State Children's Hospital
    Hershey, Pennsylvania 17033-0850
    Brain Tumor, Central Nervous System Tumor
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Fallopian Tube Cancer, Ovarian Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Prostate Cancer